Davis Capital Management Treace Medical Concepts, Inc. Transaction History
Davis Capital Management
- $115 Billion
- Q2 2024
A detailed history of Davis Capital Management transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Davis Capital Management holds 250 shares of TMCI stock, worth $1,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$1,930
Previous $3.13 Million
48.06%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TMCI
# of Institutions
131Shares Held
40.8MCall Options Held
185KPut Options Held
37.1K-
Vanguard Group Inc Valley Forge, PA4.3MShares$33.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.7MShares$28.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.29MShares$25.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.4MShares$18.5 Million0.43% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.33MShares$18 Million0.08% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $428M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...